Agentix (AGTX) Share-based Compensation (2016 - 2023)

Agentix's (AGTX) quarterly Share-based Compensation came in at $103875.0 in Q1 2023, up 1977.5% on a QoQ basis from $5000.0 in Q4 2022.

Agentix (AGTX) Share-based Compensation (2016 - 2023) Analysis & Trends

Agentix (AGTX) has 4 years of Share-based Compensation data on file, last reported at $103875.0 in Q1 2023.

Quarterly Share-based Compensation changed N/A year-over-year to $103875.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $118875.0 (changed N/A YoY) and the FY2023 annual result came in at $118875.0, changed N/A from the prior year.
Share-based Compensation improved to $103875.0 in Q1 2023, from $5000.0 in the prior quarter.
In the past five years, Share-based Compensation ranged from a high of $103875.0 in Q1 2023 to a low of $5000.0 in Q2 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Stock Comp. (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	108.10 Mn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	243.00 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	120.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	137.41 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	86.63 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	28.05 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	41.25 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Agentix	801,339.00	801,301.00	-	-

Download Data